Second, we recognize that by design, the STEP 2 trial was not a dedicated kidney outcome trial, and relatively few participants had established CKD
"That variability in sourcing is one of the biggest concerns, particularly when it comes to purity, dosing consistency and overall quality control." The FDA does not allow production of BPC-157, GHK-Cu, KPV and ipamorelin in the U.S., for example, by compounding pharmacies because of safety concerns , so people are ordering them from overseas usually from China
Compounded semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Gastrointestinal side effects, such as nausea, diarrhea, vomiting, constipation, and abdominal pain, are common with Ozempic use
